Exelixis | SCHULD



Debt Veränderung Datum
Acadia Pharmaceuticals USD 0 0 2025-03
Agios Pharmaceuticals USD 0 0 2025-03
Amgen USD 57.38B 2.72B 2025-03
AstraZeneca USD 31.65B 1.35B 2025-03
Bayer EUR 39.39B 1.31B 2025-03
BioMarin Pharmaceutical USD 595.65M 585K 2025-03
Bristol-Myers Squibb USD 49.71B 62M 2025-03
Cytokinetics USD 658.13M 1.01M 2025-03
Eisai JPY 187.52B 31.58B 2025-03
Eli Lilly USD 38.52B 4.87B 2025-03
Exelixis USD 0 0 2025-04
Genmab DKK 143M 886M 2025-03
Glaxosmithkline GBP 16.99B 927M 2024-12
Incyte USD 37.12M 840K 2025-03
Ionis Pharmaceuticals USD 1.25B 5.23M 2025-03
MacroGenics USD 0 0 2024-12
Merck USD 34.84B 2.27B 2025-03
Moderna USD 745M 683M 2025-03
Neurocrine Biosciences USD 0 0 2024-12
Novartis USD 31.26B 828M 2024-12
Pfizer USD 62.11B 2.24B 2025-03
Sanofi 17.91B 5.85B 2024-12
Takeda JPY 4.52T 324.88B 2025-03
Ultragenyx Pharmaceutical USD 0 0 2024-12
Xencor USD 154.38M 9.23M 2025-03



Exelixis SCHULD - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.